Man-Ling Liu

507 total citations
14 papers, 435 citations indexed

About

Man-Ling Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Man-Ling Liu has authored 14 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Man-Ling Liu's work include Pulmonary Hypertension Research and Treatments (4 papers), Immune Response and Inflammation (3 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Man-Ling Liu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (4 papers), Immune Response and Inflammation (3 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Man-Ling Liu collaborates with scholars based in China and Russia. Man-Ling Liu's co-authors include Zhichao Li, Ying Luo, Haiying Dong, Pengtao Zhao, Yanxia Wang, Faguang Jin, Dun-Quan Xu, Yanyan Li, Bo Zhang and Yi Liu and has published in prestigious journals such as Archives of Biochemistry and Biophysics, Gene and European Journal of Pharmacology.

In The Last Decade

Man-Ling Liu

13 papers receiving 434 citations

Peers

Man-Ling Liu
Man-Ling Liu
Citations per year, relative to Man-Ling Liu Man-Ling Liu (= 1×) peers Daixing Zhou

Countries citing papers authored by Man-Ling Liu

Since Specialization
Citations

This map shows the geographic impact of Man-Ling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man-Ling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man-Ling Liu more than expected).

Fields of papers citing papers by Man-Ling Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man-Ling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man-Ling Liu. The network helps show where Man-Ling Liu may publish in the future.

Co-authorship network of co-authors of Man-Ling Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Man-Ling Liu. A scholar is included among the top collaborators of Man-Ling Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man-Ling Liu. Man-Ling Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wang, Hui, Lu Wang, Gui‐Rong Li, et al.. (2025). Acacetin reverses hypoxic pulmonary hypertension by inhibiting hypoxia-induced proliferation of pulmonary artery smooth muscle cells via SIRT1-HMGB1 pathway. European Journal of Pharmacology. 998. 177650–177650.
2.
Liu, Man-Ling, Xiaoqing Liang, Ying Luo, et al.. (2020). Reversal of Hypoxic Pulmonary Hypertension by Hypoxia-Inducible Overexpression of Angiotensin-(1-7) in Pulmonary Endothelial Cells. Molecular Therapy — Methods & Clinical Development. 17. 975–985. 14 indexed citations
3.
Feng, Gong, Man-Ling Liu, Xiaozhou Zhang, et al.. (2020). Clinical Features of COVID-19 Patients in Xiaogan City. SN Comprehensive Clinical Medicine. 2(10). 1717–1723. 2 indexed citations
4.
Feng, Gong, Xueping Li, Chunyan Niu, et al.. (2020). Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Gene. 742. 144549–144549. 27 indexed citations
5.
Dong, Haiying, Yan Cui, Bo Zhang, et al.. (2017). Automatic regulation of NF-κB by pHSP70/IκBαm to prevent acute lung injury in mice. Archives of Biochemistry and Biophysics. 634. 47–56. 3 indexed citations
6.
Dong, Haiying, Min Xu, Zhenyu Ji, et al.. (2013). Leptin Attenuates Lipopolysaccharide or Oleic Acid-Induced Acute Lung Injury in Mice. American Journal of Respiratory Cell and Molecular Biology. 49(6). 1057–1063. 12 indexed citations
7.
Chen, Xiangjun, Bo Zhang, Yun Shi, et al.. (2013). Osthole improves acute lung injury in mice by up-regulating Nrf-2/thioredoxin 1. Respiratory Physiology & Neurobiology. 188(2). 214–222. 33 indexed citations
8.
Zhang, Bo, Min Shen, Min Xu, et al.. (2012). Role of Macrophage Migration Inhibitory Factor in the Proliferation of Smooth Muscle Cell in Pulmonary Hypertension. Mediators of Inflammation. 2012. 1–10. 42 indexed citations
9.
Liu, Man-Ling, Haiying Dong, Bo Zhang, et al.. (2012). Insulin reduces LPS-induced lethality and lung injury in rats. Pulmonary Pharmacology & Therapeutics. 25(6). 472–477. 10 indexed citations
10.
Zhang, Bo, Yanyan Li, Ying Luo, et al.. (2011). Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice. European Journal of Pharmaceutical Sciences. 44(5). 573–579. 167 indexed citations
11.
Zhang, Bo, Ying Luo, Man-Ling Liu, et al.. (2011). Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats. Microvascular Research. 83(2). 205–212. 21 indexed citations
12.
Wang, Jing, Mingqing Dong, Man-Ling Liu, et al.. (2010). Tanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension rats. European Journal of Pharmacology. 640(1-3). 129–138. 40 indexed citations
13.
Xu, Dun-Quan, Ying Luo, Yi Liu, et al.. (2010). Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats. Respiratory Research. 11(1). 32 indexed citations
14.
Xu, Min, Mingqing Dong, Fa-Le Cao, et al.. (2009). Tanshinone IIA reduces lethality and acute lung injury in LPS-treated mice by inhibition of PLA2 activity. European Journal of Pharmacology. 607(1-3). 194–200. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026